Abstract

Urease is an important virulence factor from Helicobacter pylori that enables bacterial colonization of human gastric mucosa. Specific inhibition of urease activity can be regarded as a promising adjuvant strategy for eradication of this pathogen. A group of organophosphorus inhibitors of urease, namely, aminophosphinic acid and aminophosphonic acid derivatives, were evaluated in vitro against H. pylori urease. The kinetic characteristics of recombinant enzyme activity demonstrated a competitive reversible mode of inhibition with Ki values ranging from 0.294 to 878 μM. N-n-Hexylaminomethyl-P-aminomethylphosphinic acid and N-methylaminomethyl-P-hydroxymethylphosphinic acid were the most effective inhibitors (Ki = 0.294 μM and 1.032 μM, respectively, compared to Ki = 23 μM for the established urease inhibitor acetohydroxamic acid).The biological relevance of the inhibitors was verified in vitro against a ureolytically active Escherichia coli Rosetta host that expressed H. pylori urease and against a reference strain, H. pylori J99 (CagA+/VacA+). The majority of the studied compounds exhibited urease-inhibiting activity in these whole-cell systems. Bis(N-methylaminomethyl)phosphinic acid was found to be the most effective inhibitor in the susceptibility profile studies of H. pylori J99. The cytotoxicity of nine structurally varied inhibitors was evaluated against four normal human cell lines and was found to be negligible.

Highlights

  • Helicobacter pylori bacilli are recognized as the most common bacterial agent that causes infections in humans

  • Mobley et al, when using an E. coli SE5000 strain transformed with a 15.3-kbp plasmid that encoded both H. pylori urease and the NixA nickel transporter, obtained recombinant urease with good catalytic activity

  • This plasmid was created by the insertion of a fragment, much longer than the urease operon, that was generated by a random restriction of the H. pylori genome that conferred a urease-positive phenotype to E. coli cells

Read more

Summary

Introduction

Helicobacter pylori bacilli are recognized as the most common bacterial agent that causes infections in humans. H. pylori was the first bacterial species that was proven to cause cancer, and it is classified as a group I carcinogen by the International Agency for Research on Cancer

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call